Skip to navigation Skip to content

Clinical Trial: Ofatumumab

Share

Details
Type of MS: RRMS|SPMS
Treatment mode of action: to improve immune function
Number of Subjects: 550
Medication: ofatumumab
Location: California
Institutions: Palo Alto Medical Foundation
795 El Camino Real
Palo Alto, CA 94301 Contact Information
Renee Kaneshiro
650-853-4744

Funding:

Novartis

Description

MS study to evaluate the effectiveness of ofatumumab after transitioning from oral therapy, in adults 18 to 60 with relapsing MS experiencing breakthrough disease.  Study participation includes in-person visits, blood draws, MRI appointments, and use of electronic devices and technology to track daily activity.

Share

© 2023 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.